Harvard University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Harvard University sits in the top decile of US sponsors by registered trial count (#456 of 15,742 sponsors by registered trial count).
Harvard University: 37 sponsored US clinical trials, 2 recruiting.
Harvard University sponsors 37 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 32 completed. 0 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Anxiety, with 4 trials.
Top-decile sponsor footprint
Harvard University ranks in the top decile of sponsors by registered trial count (#456 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
32 of 34 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (94.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
37 total, page 1 of 1
Digital Single Session Intervention for Youth Mental Health
NCT05449002
Testing FIRST in Youth Outpatient Psychotherapy
NCT04725721
Innovative Family Prevention With Latino Siblings in Disadvantaged Settings
NCT03706014
Testing the Effects of Project Calm in Ukrainian Schools
NCT06217705
Brief Interventions on Social Media to Reduce Suicide Risk (Intervention 3)
NCT06114849
Brief Interventions on Social Media to Reduce Suicide Risk (Intervention 1)
NCT06114875
The Ukrainian Student Problem Solving Project
NCT06064578
Project THINK: Trial of a Brief Cognitive Restructuring Intervention
NCT05720741
Music-based Mindfulness Intervention for Elevated Race-based Anxiety in the Black Community
NCT05746312
iWellness Study to Evaluate a Mental Health App for Students
NCT05234970
Patient Perceptions of Physician Education and Quality by Race
NCT04940234
Willingness to Participate in Clinical Trials Among Black and African Americans
NCT04938895
StriveWeekly Online Mental Health Trial Post-pandemic
NCT04927845
Project SOLVE: Trial of a Brief Digital Problem-solving Intervention
NCT04806321
Digital Narrative Bibliotherapy as a Scalable Intervention for Suicidal Thoughts
NCT05351645
Minnesota COVID-19 Testing Project
NCT04568889
A Mindful Community for People With ALS and Their Primary Caregivers
NCT05595850
Persuasion in Medicine: Experimental Evidence on Sender and Signal Effects
NCT04160975
Mindful Attention to Variability in Everyday Memory
NCT03949868
Mindfully Attending to Pain Sensations
NCT03939949
Evaluating a Mobile App for Students Seeking Care for Depression and Anxiety at Harvard University Health Services
NCT03552900
Brief Online Help-seeking Barrier Reduction Intervention
NCT03633825
Attention to Variability During Infertility
NCT03712982
Sugar Sweetened Beverage Labeling Support
NCT02947802
Effects of a Single-session Implicit Theories of Personality Intervention on Early Adolescent Psychopathology
NCT03132298
Using Neuroimaging to Understand Children's Mental Health and Treatment Outcomes
NCT03112265
An Online Mindfulness Intervention for People With ALS and Their Caregivers
NCT03095989
Student Outcomes of Integrative Mental Health Services
NCT02877875
Connecticut Child STEPs
NCT03153904
The Power of Curiosity: Leveraging Curiosity to Motivate People to Complete Health Risk Assessments
NCT01875913
Social Network Interventions in Rural Honduras
NCT01672580
Child STEPS for Youth Mental Health in Maine Sustainability
NCT03112304
Lottery Incentives for Moving
NCT01278654
Couples Therapy for Alcoholic Patients
NCT01659957
Testing Strategies for Increasing Exercise
NCT01139541
Behavioral Couples Therapy for Female Drug-Abusing Patients
NCT01189305
Maine Implementation Study - Phase III
NCT02229305
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
Therapeutic Areas
What is open in the Harvard University pipeline
2 recruiting of 37 indexed (5% open); 32 completed (86%).
Phase mix: 0 late (III/IV) vs 2 early (I/II) (early-phase heavy).
Top condition: Anxiety (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Harvard University: open-pipeline peers nationwide
Peers matched on 37 registered trials and 5% open enrollment, not the therapeutic-area sidebar.
Harvard University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 37 trials (± recruiting share)
- Appalachian State University · 37 trials · 3% recruiting
- Bracco Diagnostics · 37 trials · 3% recruiting
- Carnegie Mellon University · 37 trials · 11% recruiting
- Cutera · 37 trials · 0% recruiting
Sponsors near 5% open enrollment (± trial volume)
- C. R. Bard · 5% recruiting · 75 trials
- Denver Health and Hospital Authority · 5% recruiting · 73 trials
- Almirall, S.A. · 5% recruiting · 19 trials
- Cordis US · 5% recruiting · 19 trials
Related
What to do with this Harvard University page
37 registered trials is a research-attention snapshot, not an endorsement of Harvard University or any single study.
- 2 of Harvard University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Anxiety is the condition Harvard University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Anxiety trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Harvard University pipeline card: 37 registered trials from official public datasets.Report a data error.